Global Long-Acting Injectables Market Insights, Forecast to 2028

  • Report ID:245499
  • Industry Name: Medical Care
  • Publishing Date: Jul-22
  • No. of Pages: 93
                              
Long-Acting Injectables market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Long-Acting Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Small and Middle Sized Molecule Large Sized Molecule Segment by Application Schizophrenia Other Psychotic Disorders By Company Eli Lilly Pfizer GlaxoSmithKline Johnson & Johnson Lupin Zogenix DURECT Medincel By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Small and Middle Sized Molecule 1.2.3 Large Sized Molecule 1.3 Market by Application 1.3.1 Global Long-Acting Injectables Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Schizophrenia 1.3.3 Other Psychotic Disorders 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Long-Acting Injectables Market Perspective (2017-2028) 2.2 Long-Acting Injectables Growth Trends by Region 2.2.1 Long-Acting Injectables Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Long-Acting Injectables Historic Market Size by Region (2017-2022) 2.2.3 Long-Acting Injectables Forecasted Market Size by Region (2023-2028) 2.3 Long-Acting Injectables Market Dynamics 2.3.1 Long-Acting Injectables Industry Trends 2.3.2 Long-Acting Injectables Market Drivers 2.3.3 Long-Acting Injectables Market Challenges 2.3.4 Long-Acting Injectables Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Long-Acting Injectables Players by Revenue 3.1.1 Global Top Long-Acting Injectables Players by Revenue (2017-2022) 3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2017-2022) 3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Long-Acting Injectables Revenue 3.4 Global Long-Acting Injectables Market Concentration Ratio 3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2021 3.5 Long-Acting Injectables Key Players Head office and Area Served 3.6 Key Players Long-Acting Injectables Product Solution and Service 3.7 Date of Enter into Long-Acting Injectables Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Long-Acting Injectables Breakdown Data by Type 4.1 Global Long-Acting Injectables Historic Market Size by Type (2017-2022) 4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2023-2028) 5 Long-Acting Injectables Breakdown Data by Application 5.1 Global Long-Acting Injectables Historic Market Size by Application (2017-2022) 5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Long-Acting Injectables Market Size (2017-2028) 6.2 North America Long-Acting Injectables Market Size by Type 6.2.1 North America Long-Acting Injectables Market Size by Type (2017-2022) 6.2.2 North America Long-Acting Injectables Market Size by Type (2023-2028) 6.2.3 North America Long-Acting Injectables Market Share by Type (2017-2028) 6.3 North America Long-Acting Injectables Market Size by Application 6.3.1 North America Long-Acting Injectables Market Size by Application (2017-2022) 6.3.2 North America Long-Acting Injectables Market Size by Application (2023-2028) 6.3.3 North America Long-Acting Injectables Market Share by Application (2017-2028) 6.4 North America Long-Acting Injectables Market Size by Country 6.4.1 North America Long-Acting Injectables Market Size by Country (2017-2022) 6.4.2 North America Long-Acting Injectables Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Long-Acting Injectables Market Size (2017-2028) 7.2 Europe Long-Acting Injectables Market Size by Type 7.2.1 Europe Long-Acting Injectables Market Size by Type (2017-2022) 7.2.2 Europe Long-Acting Injectables Market Size by Type (2023-2028) 7.2.3 Europe Long-Acting Injectables Market Share by Type (2017-2028) 7.3 Europe Long-Acting Injectables Market Size by Application 7.3.1 Europe Long-Acting Injectables Market Size by Application (2017-2022) 7.3.2 Europe Long-Acting Injectables Market Size by Application (2023-2028) 7.3.3 Europe Long-Acting Injectables Market Share by Application (2017-2028) 7.4 Europe Long-Acting Injectables Market Size by Country 7.4.1 Europe Long-Acting Injectables Market Size by Country (2017-2022) 7.4.2 Europe Long-Acting Injectables Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Long-Acting Injectables Market Size (2017-2028) 8.2 Asia-Pacific Long-Acting Injectables Market Size by Type 8.2.1 Asia-Pacific Long-Acting Injectables Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Long-Acting Injectables Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Long-Acting Injectables Market Share by Type (2017-2028) 8.3 Asia-Pacific Long-Acting Injectables Market Size by Application 8.3.1 Asia-Pacific Long-Acting Injectables Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Long-Acting Injectables Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Long-Acting Injectables Market Share by Application (2017-2028) 8.4 Asia-Pacific Long-Acting Injectables Market Size by Region 8.4.1 Asia-Pacific Long-Acting Injectables Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Long-Acting Injectables Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Long-Acting Injectables Market Size (2017-2028) 9.2 Latin America Long-Acting Injectables Market Size by Type 9.2.1 Latin America Long-Acting Injectables Market Size by Type (2017-2022) 9.2.2 Latin America Long-Acting Injectables Market Size by Type (2023-2028) 9.2.3 Latin America Long-Acting Injectables Market Share by Type (2017-2028) 9.3 Latin America Long-Acting Injectables Market Size by Application 9.3.1 Latin America Long-Acting Injectables Market Size by Application (2017-2022) 9.3.2 Latin America Long-Acting Injectables Market Size by Application (2023-2028) 9.3.3 Latin America Long-Acting Injectables Market Share by Application (2017-2028) 9.4 Latin America Long-Acting Injectables Market Size by Country 9.4.1 Latin America Long-Acting Injectables Market Size by Country (2017-2022) 9.4.2 Latin America Long-Acting Injectables Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Long-Acting Injectables Market Size (2017-2028) 10.2 Middle East & Africa Long-Acting Injectables Market Size by Type 10.2.1 Middle East & Africa Long-Acting Injectables Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Long-Acting Injectables Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Long-Acting Injectables Market Share by Type (2017-2028) 10.3 Middle East & Africa Long-Acting Injectables Market Size by Application 10.3.1 Middle East & Africa Long-Acting Injectables Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Long-Acting Injectables Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Long-Acting Injectables Market Share by Application (2017-2028) 10.4 Middle East & Africa Long-Acting Injectables Market Size by Country 10.4.1 Middle East & Africa Long-Acting Injectables Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Long-Acting Injectables Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Details 11.1.2 Eli Lilly Business Overview 11.1.3 Eli Lilly Long-Acting Injectables Introduction 11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2017-2022) 11.1.5 Eli Lilly Recent Developments 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Long-Acting Injectables Introduction 11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2017-2022) 11.2.5 Pfizer Recent Developments 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Details 11.3.2 GlaxoSmithKline Business Overview 11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction 11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2017-2022) 11.3.5 GlaxoSmithKline Recent Developments 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Long-Acting Injectables Introduction 11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2017-2022) 11.4.5 Johnson & Johnson Recent Developments 11.5 Lupin 11.5.1 Lupin Company Details 11.5.2 Lupin Business Overview 11.5.3 Lupin Long-Acting Injectables Introduction 11.5.4 Lupin Revenue in Long-Acting Injectables Business (2017-2022) 11.5.5 Lupin Recent Developments 11.6 Zogenix 11.6.1 Zogenix Company Details 11.6.2 Zogenix Business Overview 11.6.3 Zogenix Long-Acting Injectables Introduction 11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2017-2022) 11.6.5 Zogenix Recent Developments 11.7 DURECT 11.7.1 DURECT Company Details 11.7.2 DURECT Business Overview 11.7.3 DURECT Long-Acting Injectables Introduction 11.7.4 DURECT Revenue in Long-Acting Injectables Business (2017-2022) 11.7.5 DURECT Recent Developments 11.8 Medincel 11.8.1 Medincel Company Details 11.8.2 Medincel Business Overview 11.8.3 Medincel Long-Acting Injectables Introduction 11.8.4 Medincel Revenue in Long-Acting Injectables Business (2017-2022) 11.8.5 Medincel Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Small and Middle Sized Molecule Table 3. Key Players of Large Sized Molecule Table 4. Global Long-Acting Injectables Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Long-Acting Injectables Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Long-Acting Injectables Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Long-Acting Injectables Market Share by Region (2017-2022) Table 8. Global Long-Acting Injectables Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Long-Acting Injectables Market Share by Region (2023-2028) Table 10. Long-Acting Injectables Market Trends Table 11. Long-Acting Injectables Market Drivers Table 12. Long-Acting Injectables Market Challenges Table 13. Long-Acting Injectables Market Restraints Table 14. Global Long-Acting Injectables Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Long-Acting Injectables Revenue Share by Players (2017-2022) Table 16. Global Top Long-Acting Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2021) Table 17. Ranking of Global Top Long-Acting Injectables Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Long-Acting Injectables Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Long-Acting Injectables Product Solution and Service Table 21. Date of Enter into Long-Acting Injectables Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Long-Acting Injectables Revenue Market Share by Type (2017-2022) Table 25. Global Long-Acting Injectables Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Long-Acting Injectables Revenue Market Share by Type (2023-2028) Table 27. Global Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Long-Acting Injectables Revenue Share by Application (2017-2022) Table 29. Global Long-Acting Injectables Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Long-Acting Injectables Revenue Share by Application (2023-2028) Table 31. North America Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Long-Acting Injectables Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Long-Acting Injectables Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million) Table 61. Eli Lilly Company Details Table 62. Eli Lilly Business Overview Table 63. Eli Lilly Long-Acting Injectables Product Table 64. Eli Lilly Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 65. Eli Lilly Recent Developments Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Long-Acting Injectables Product Table 69. Pfizer Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 70. Pfizer Recent Developments Table 71. GlaxoSmithKline Company Details Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Long-Acting Injectables Product Table 74. GlaxoSmithKline Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 75. GlaxoSmithKline Recent Developments Table 76. Johnson & Johnson Company Details Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Long-Acting Injectables Product Table 79. Johnson & Johnson Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 80. Johnson & Johnson Recent Developments Table 81. Lupin Company Details Table 82. Lupin Business Overview Table 83. Lupin Long-Acting Injectables Product Table 84. Lupin Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 85. Lupin Recent Developments Table 86. Zogenix Company Details Table 87. Zogenix Business Overview Table 88. Zogenix Long-Acting Injectables Product Table 89. Zogenix Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 90. Zogenix Recent Developments Table 91. DURECT Company Details Table 92. DURECT Business Overview Table 93. DURECT Long-Acting Injectables Product Table 94. DURECT Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 95. DURECT Recent Developments Table 96. Medincel Company Details Table 97. Medincel Business Overview Table 98. Medincel Long-Acting Injectables Product Table 99. Medincel Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 100. Medincel Recent Developments Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Long-Acting Injectables Market Share by Type: 2021 VS 2028 Figure 2. Small and Middle Sized Molecule Features Figure 3. Large Sized Molecule Features Figure 4. Global Long-Acting Injectables Market Share by Application: 2021 VS 2028 Figure 5. Schizophrenia Case Studies Figure 6. Other Psychotic Disorders Case Studies Figure 7. Long-Acting Injectables Report Years Considered Figure 8. Global Long-Acting Injectables Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Long-Acting Injectables Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Long-Acting Injectables Market Share by Region: 2021 VS 2028 Figure 11. Global Long-Acting Injectables Market Share by Players in 2021 Figure 12. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2021 Figure 14. North America Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 16. North America Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 17. North America Long-Acting Injectables Market Size Share by Country (2017-2028) Figure 18. United States Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 22. Europe Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 23. Europe Long-Acting Injectables Market Size Share by Country (2017-2028) Figure 24. Germany Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific Long-Acting Injectables Market Size Share by Region (2017-2028) Figure 34. China Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 42. Latin America Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 43. Latin America Long-Acting Injectables Market Size Share by Country (2017-2028) Figure 44. Mexico Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa Long-Acting Injectables Market Size Share by Country (2017-2028) Figure 50. Turkey Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 54. Pfizer Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 55. GlaxoSmithKline Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 56. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 57. Lupin Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 58. Zogenix Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 59. DURECT Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 60. Medincel Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.